CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Vyant Bio Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Vyant Bio Inc
2 Executive Campus
2370 State Route 70, Suite 310
Phone: (201) 528-9200p:201 528-9200 CHERRY HILL, NJ  08002  United States Fax: (302) 655-5049f:302 655-5049
This company ceased filing statements with the SEC on 5/15/2023.
This company is no longer actively traded on any major stock exchange.
Business Summary
Vyant Bio, Inc. has no continuing operating activities other than the winddown and closure of its business. The Company is seeking to obtain its shareholders’ approval for the voluntary liquidation and dissolution of the Company, pursuant to a plan of liquidation and dissolution.
(Source: PRESS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-YesYesYes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202212/31/2022YesYes-YesYes

Industries
SIC Code Description
8071 Medical laboratories
6726 Unit investment trusts, face-amount certificate offices

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board JohnFletcher 77 3/31/2021 3/31/2021
President, Chief Executive Officer, Chief Financial Officer Andrew D.Lafrence 60 12/1/2023 8/1/2019
Director John A.Roberts 64 2/3/2023 7/11/2016
3 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Response Genetics Inc 1640 Marengo St Fl 7th LOS ANGELES CA United States
StemoniX, Inc. 13300 67th Ave N Maple Grove MN United States
Gentris Corporation 133 Southcenter Court Morrisville North Carolina United States
vivoPharm Pty. Ltd 240 Plenty Road BUNDOORA VIC Australia

Business Names
Business Name
Response Genetics, Inc.
StemoniX, Inc.
vivoPharm Pty. Ltd

General Information
Number of Employees: 8 (As of 3/15/2023)
Outstanding Shares: 6,328,752 (As of 8/4/2023)
Shareholders: 81
Stock Exchange: MNC
Federal Tax Id: 043462475
Fax Number: (302) 655-5049
Email Address: contact@cancergenetics.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, December 1, 2024